Analysis of Orthopedic Patients Response to New Pain Modulating Substances and Drugs

NCT03138460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-08-31

No results posted yet for this study

Summary

Data of patient reported outcomes (PRO) are collected during treatment with various pain alleviation methods (drugs or substances)

Conditions

  • Low Back Pain

Interventions

OTHER

standard medications crossed over to cannabis

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • dror robinson, md · head orthopedic research unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03138460 on ClinicalTrials.gov